What’re a better buy? Cronos Group or Sundial Growers shares
- Cronos Group shares remain in the focus of investors
- Altria could buy the rest of the Cronos for approximately $2.0 billion
- Sundial Growers has focused on restructuring activities
Follow Invezz on Telegram, Twitter, and Google News for instant updates >
Cronos Group Inc (NASDAQ: CRON) remains in the focus of investors after New Cannabis Ventures reported that the Altria Group Inc (NYSE: MO) could buy the remaining outstanding shares of the cannabis company.
Cronos Group shares advanced above $6.7 after this news but, shares have weakened from their recent highs, and the current price stands at $5.6.
Altria Group currently has a 45% stake in Cronos that it bought in 2019 for C$2.40 billion(C$16.25 per share), while New Cannabis Ventures estimates that Altria could buy the rest of the Cronos for approximately $2.0 billion.
It is also important to say that Altria also acquired warrants at C$19 that would give it majority ownership if exercised. Cronos Group is a good strategic fit for Altria, and the combined company could be more aggressive in penetrating the American cannabis industry.
Looking forward, Cronos Group has solid growth prospects; still, the company is not profitable on a yearly basis.
Similar to peers, the company is burning cash, but if the acquisition goes to realization, shares of Cronos will advance above the current levels.
On the other side, Sundial Growers Inc. (NASDAQ: SNDL) has focused on restructuring activities that include workforce and other cost reductions, but the stock will not obtain more investor interest until the revenue base expands.
The cannabis revenue for the second quarter of 2021 has increased only 8% compared to the previous quarter, while the company’s CEO said that Sundial has no interest in pursuing unprofitable revenue growth.
Sundial Growers shares have skyrocketed above $3.9 in February 2021; since then, the price has collapsed, and the current share price stands at $0.72. Like Cronos Group, Sundial Growers also has a problem with cash burning, and the company is also not profitable on a yearly basis.
Cronos Group shares have weakened from their recent highs above $6.7, registered on 08th November, to $5.4, while the current price stands at $5.6.
If the price jumps again above $6 resistance, it would be a signal to buy shares of this company, and the next price target could be around $6.7 or even above.
Sundial Growers shares continue to trade near monthly lows, and if the price falls below $0.60, the next target could be $0.50 support.
On the other side, if the price jumps above $0.80, it would signal trading shares, and the next target could be at $1 or even above.
Cronos Group and Sundial Growers have solid growth prospects, but both companies are not profitable and have problems with cash burning. Cronos Group remains in the focus of investors after the news that the Altria Group could buy the remaining outstanding shares of this company.
New Cannabis Ventures estimates that Altria could buy the rest of the Cronos for approximately $2.0 billion, and because of this, Cronos shares probably represent a better buying option at the moment.
Copy expert traders easily with eToro. Invest in stocks like Tesla & Apple. Instantly trade ETFs like FTSE 100 & S&P 500. Sign-up in minutes.
77% of retail CFD accounts lose money.